Cargando…
Efficacy and safety of SARS-CoV-2 vaccination in liver transplant recipients
Autores principales: | Meunier, Lucy, Sanavio, Mathilde, Meszaros, Magdalena, Faure, Stéphanie, Bedoya, José Ursic, Echenne, Maxime, Debourdeau, Antoine, Pageaux, Georges-Philippe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Association for the Study of the Liver. Published by Elsevier B.V.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9252414/ http://dx.doi.org/10.1016/S0168-8278(22)01859-1 |
Ejemplares similares
-
Mycophenolate mofetil decreases humoral responses to three doses of SARS‐CoV‐2 vaccine in liver transplant recipients
por: Meunier, Lucy, et al.
Publicado: (2022) -
SARS-CoV-2 vaccination in liver transplant recipients: factors affecting immune response and refusal to vaccine
por: Raszeja-Wyszomirska, Joanna, et al.
Publicado: (2022) -
Does m-RNA vaccination protect from Sars-Cov2 (asymptomatic) infection in liver transplant recipients?
por: Comandini, Ubaldo Visco, et al.
Publicado: (2022) -
Predictive factors of antibody response after anti-SARS-CoV-2 vaccine in liver transplant recipients
por: Kounis, Ilias, et al.
Publicado: (2022) -
SARS-CoV-2 infection in liver transplant recipients-a single center case series from Romania
por: Husar-Sburlan, Ioana-Alexandra, et al.
Publicado: (2022)